The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to the FDA.

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

"We're So Doomed": People Are Sharing Their Unfiltered Reactions To RFK Jr. Being Confirmed As Health Secretary, And It's Bleak Several Different Brands Of Canned Tuna Have Been Recalled Due Their ...

Then, the Ozempic boom happened. Celebrities like Khloé Kardashian and Oprah Winfrey were sharing their experience with ...

The rash of robberies of weight-loss drugs comes amid soaring sales of the medication in a country where achieving a finely tuned body is revered and that, like ... Ozempic sales grew from $27.5 ...

“There’s a lot of hype and excitement around GLP-1 and like medications,” Youssef. “And the thing I want to see is long-term safety data. Whenever we give medication to a large portion of ...

I LOVE YOU!!!!” This is great but she never says this to me. Am I being a wimp because I would like some of the same affection? – Second Best Dear Best: If it’s wimpy to want to know that we ...

But 25-year-old Madison Burgess has thrown caution to the wind by opting to micro-dose the drug. The Michigan native revealed ...